FDA Approves Rituxan Biosimilar Ruxience for 2 ANCA Vasculitis Subtypes – ANCA Vasculitis News

FDA Approves Rituxan Biosimilar Ruxience for 2 ANCA Vasculitis Subtypes – ANCA Vasculitis News

FDA Approves Rituxan Biosimilar Ruxience for 2 ANCA Vasculitis Subtypes – ANCA Vasculitis News
Published on 2019-07-30